NLM Digital Collections

Search

Start Over Collections Health Policy and Services Research ✖Remove constraint Collections: Health Policy and Services Research Subjects Government Regulation ✖Remove constraint Subjects: Government Regulation

41. Short-term, limited-duration insurance and risks to California's insurance market

Author(s):
Palanker, Dania, author
Lucia, Kevin, author
Volk, JoAnn, author
Schwab, Rachel, author
Publication:
[Oakland, Calif.] : California Health Care Foundation, April 2018
Subject(s):
Health Insurance Exchanges
Insurance, Health
Health Care Sector
Insurance Benefits
Government Regulation
State Government
Humans
California
United States
United States.

42. Ensuring health plan mergers benefit the community: California regulators and infrastructure investment programs

Author(s):
Shore, Karen, author
Publication:
[Oakland, Calif.] : California Health Care Foundation, July 2018
Subject(s):
For-Profit Insurance Plans -- organization & administration
Health Care Coalitions -- organization & administration
Investments
Insurance Benefits
Insurance Carriers -- statistics & numerical data
Insurance, Health
Safety-net Providers
For-Profit Insurance Plans -- economics
Government Regulation
Health Care Coalitions -- economics
Health Care Sector
Organizational Case Studies
State Government
Humans
California
United States

43. Imported seafood safety: FDA and USDA could strengthen efforts to prevent unsafe drug residues : report to the chairman, Committee on Appropriations, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, September 2017
Subject(s):
Anti-Bacterial Agents -- adverse effects
Commerce -- standards
Drug Residues -- standards
Fishes
Food Contamination -- prevention & control
Food Safety
Food Supply -- standards
Hazard Analysis and Critical Control Points
Seafood
Aquaculture -- standards
Catfishes
Food Safety -- methods
Government Regulation
Public Health
Humans
Asia
Canada
United States
United States. Department of Agriculture.
United States. Food and Drug Administration.

44. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Analgesics, Opioid -- therapeutic use
Drug Utilization Review
Government Regulation
Inappropriate Prescribing
Medicare Part D
Prescription Drug Misuse
Fraud -- prevention & control
Opioid-Related Disorders
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

45. High-containment laboratories: coordinated efforts needed to further strengthen oversight of select agents : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, November 2, 2017
Subject(s):
Biological Warfare Agents
Chemical Warfare Agents
Government Regulation
Laboratories
Bacterial Toxins
Interinstitutional Relations
Humans
Canada
United Kingdom
United States
Centers for Disease Control and Prevention (U.S.)
United States. Animal and Plant Health Inspection Service.

46. VA health care: improved policies and oversight needed for reviewing and reporting providers for quality and safety concerns : report to the chairman, Committee on Veterans' Affairs, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, November 2017
Subject(s):
Clinical Competence
Government Regulation
Hospitals, Veterans
Patient Safety
Quality of Health Care
Documentation
Health Policy
Veterans Health
Humans
United States
United States. Veterans Health Administration.

47. VA health care: improved oversight needed for reviewing and reporting providers for quality and safety concerns : testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, November 29, 2017
Subject(s):
Clinical Competence
Government Regulation
Hospitals, Veterans
Patient Safety
Quality of Health Care
Documentation
Veterans Health
Humans
United States
United States. Veterans Health Administration.

48. Medicaid: further action needed to expedite use of national data for program oversight : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, December 2017
Subject(s):
Data Collection
Government Regulation
Information Systems
Medicaid
Federal Government
Fraud -- prevention & control
Mandatory Reporting
State Government
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

49. FDA medical device reviews: evaluation is needed to assure requests for additional information follow a least burdensome approach : report to Congressional requestors

Publication:
Washington, DC : United States Government Accountability Office, December 2017
Subject(s):
Device Approval -- standards
Equipment Safety
Federal Government
Forecasting
Government Regulation
Inservice Training
Humans
United States
United States. Food and Drug Administration.

50. Prescription opioids: Medicare should expand oversight efforts to reduce the risk of harm : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, January 17, 2018
Subject(s):
Drug and Narcotic Control
Inappropriate Prescribing -- prevention & control
Medicare Part D -- statistics & numerical data
Opioid-Related Disorders
Prescription Drug Misuse -- statistics & numerical data
Analgesics, Opioid -- adverse effects
Fraud -- prevention & control
Government Regulation
Inappropriate Prescribing -- statistics & numerical data
Medicare Part D -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)